Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q3 2025 value amounting to 0.88%.

  • Barinthus Biotherapeutics' Return on Invested Capital fell 4800.0% to 0.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.43% for FY2024, which is 500.0% down from last year.
  • Per Barinthus Biotherapeutics' latest filing, its Return on Invested Capital stood at 0.88% for Q3 2025, which was down 4800.0% from 0.7% recorded in Q2 2025.
  • Barinthus Biotherapeutics' 5-year Return on Invested Capital high stood at 0.02% for Q3 2022, and its period low was 0.88% during Q3 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' median Return on Invested Capital value was 0.41% (recorded in 2023), while the average stood at 0.34%.
  • Per our database at Business Quant, Barinthus Biotherapeutics' Return on Invested Capital soared by 800bps in 2022 and then tumbled by -4800bps in 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' Return on Invested Capital (Quarter) stood at 0.18% in 2021, then skyrocketed by 44bps to 0.1% in 2022, then crashed by -313bps to 0.42% in 2023, then decreased by -11bps to 0.47% in 2024, then crashed by -88bps to 0.88% in 2025.
  • Its last three reported values are 0.88% in Q3 2025, 0.7% for Q2 2025, and 0.58% during Q1 2025.